[Results of a cooperative clinical study of the new antineoplastic antibiotic rubomycin].
D000208:Acute Disease; D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D003864:Depression, Chemical; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006410:Hematopoiesis / Q000187:drug effects*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000188:drug therapy*; D008048:Lip Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008441:Maxillary Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000188:drug therapy*; D009447:Neuroblastoma / Q000188:drug therapy*; D012516:Osteosarcoma / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D012468:Salivary Gland Neoplasms / Q000188:drug therapy; D012509:Sarcoma; D012878:Skin Neoplasms / Q000188:drug therapy*; D013724:Teratoma / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy*; D014328:Trophoblastic Neoplasms / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic
Rezul'taty kooperirovannogo klinicheskogo izucheniia novogo protivoopukholevnogo antibiotika rubomitsina.